ContractPost-Authorisation Study Agreement • May 11th, 2020
Contract Type FiledMay 11th, 2020POST-AUTHORISATION STUDY AGREEMENT SMLOUVA O PROVEDENÍ POREGISTRAČNÍ STUDIE For Protocol CC-10004-PSOR-013 APPRECIATE™ (APREmilast ClinIcAl Treatment Experience in psoriasis): A Multi-center, Retrospective Observational Study of Real-World Experience of Psoriasis Patients Treated with Apremilast in Clinical Dermatology Practice. Pro protokol CC-10004-PSOR-013 APPRECIATE™ (APREmilast ClinIcAl Treatment Experience in psoriasis, zkušenosti s léčbou apremilastem u lupénky v klinické praxi):multicentrická, retrospektivní observační studie reálných zkušeností pacientů s lupénkou léčených apremilastem v klinické dermatologické praxi. This post-authorisation study agreement (hereinafter, the “Agreement”) is by and between: Tato smlouva o provedení poregistrační studie (dále„smlouva”), byla uzavřena mezi těmito stranami: Celgene International II Sàrl, a limited liability company organized under the laws of Switzerland, having its principal office at Rue de Pré-Jorat 14, 2108 Couvet, Switzerland